Effects of N-3 PUFAs Supplementation on Insulin Resistance and Inflammatory Biomarkers in Hemodialysis Patients

REFERENCES

• Koorts AM, Viljoen M, Kruger MC, et al. Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids. 2002; 67: 13–18
   PubMed Web of Science ®Google Scholar
• Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n–3 fatty acids in humans. Am J Clin Nutr. 2006; 83: S1467–S1476
   PubMed Web of Science ®Google Scholar
• de Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA, Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb. 1994; 14: 1829–1836
   PubMed Web of Science ®Google Scholar
• Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol. 1993; 168: 915–922
   PubMed Web of Science ®Google Scholar
• Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long chain n-3 fatty acids and the risk of sudden death. NEJM 2002; 346: 1113–1118
   PubMed Web of Science ®Google Scholar
• Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447–455
   PubMed Web of Science ®Google Scholar
• Leaf A, Kang JX, Xiao YF, al et. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003; 107: 2646–2652
   PubMed Web of Science ®Google Scholar
• Delarue J, Couet C, Cohen R, et al. Effects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans. Am J Physiol. 1996; 270: E353–E362
   PubMedGoogle Scholar
• Laaksonen D, Nyyssonen K, Niskanen L, Rissanen T, Salonen J. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med. 2005; 165: 193–199
   PubMed Web of Science ®Google Scholar
• Storlien LH, Pan DA, Kriketos AD, et al. Skeletal muscle membrane lipids and insulin resistance. Lipids. 1996; 31: 261S–265S
   PubMed Web of Science ®Google Scholar
• Rašić Zorica G, Peruničić S, Plješa LJ, Bokan LJ. Insulin resistance and dyslipidemia in hemodialysis patients. Diabetologia 1997; 40(Suppl.1)A421
   PubMedGoogle Scholar
• Rašic-Milutinović Z, Perunicic G, Plješa S, Milić N. Insulin resistance syndrome and other cardiovascular risk factors in hemodialysis patients. Cardionephrology 8, 10thAssisi European Meeting on Cardionephrology, Assisi. April, 1–32004, 49–52
   Google Scholar
• Rašić Z, Peruničić G, Plješa S, Ristić V. Serum phospholipids non-esterified very long-chain PUFA and insulin sensitivity in hemodialysis patients. Nephrol Dial Transplant 2003; 18(4)447, (T524)
   PubMedGoogle Scholar
• Risitc V, Tepšić V, Ristić-Medic D, Perunicic G, Rasic Z, Poštić M, Arsić A, Blaženčić V, Ristić G. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialysis patients. Renal Failure. 2006; 28: 211–216
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia. 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Kates M. Techniques of Lipidology. Elsevier Publ. Co, Amsterdam 1972
   Google Scholar
• Metcalfe LD, Schmitz AA. Annal. Chem 1961; 33: 363
   Web of Science ®Google Scholar
• Taccacone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler RG, Tedesco M, Maccarone M. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006; 69: 1450–1454
   PubMed Web of Science ®Google Scholar
• Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. New Engl J Med. 1993; 328: 238–244
   PubMed Web of Science ®Google Scholar
• Min Y, Ghrebremeskel K, Lowy C, Thomas B, Crawford MA. Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. Diabetologia. 2004; 47: 75–81
   PubMed Web of Science ®Google Scholar
• Pan DA, Lillioja S, Milner MR, et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest. 1995; 96: 2802–2808
   PubMed Web of Science ®Google Scholar
• Pischon T, Hankinson S, Hotamisligil G, Rifai N, Willett W, Rimm E. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003; 108: 155–160
   PubMed Web of Science ®Google Scholar
• Cho HP, Nakamura M, Clarke SD. Cloning, expression and fatty acids regulation of the human delta-5 desaturase. J Biol Chem. 1999; 274: 37335–39339
   PubMed Web of Science ®Google Scholar
• Graber R, Sumida C, Nunez EA. Fatty acids and cell signal transduction. J Lipid Mediat Cell Signal. 1994; 9: 91–116
   PubMedGoogle Scholar
• Caughey GE, Mantzioris E, Gibson RA, Gleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin I beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr. 1996; 63: 116–122
   PubMed Web of Science ®Google Scholar
• Endres S, Ghorbam R, Kelley VE, Georgilis K, Lonnemann G, Van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989; 320: 265–271
   PubMed Web of Science ®Google Scholar
• Song MK, Hwan IK, Rosenthal MJ, et al. Antidiabetic action of arachidonic acid and zinc in genetically diabetogenic Goto-Kakizaki rats. Metabolism. 2003; 52: 7–12
   PubMed Web of Science ®Google Scholar
• Friedman AN, Moe SM, Perkins SM, Li Y, Watkins BA. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis. 2006; 47: 1064–1071
   PubMed Web of Science ®Google Scholar
• Rustan AC, Nenester MS, Drevon CA. Omega-3 and omega-6 fatty acids in the insulin resistance syndrome. Lipid and lipoprotein metabolism and atherosclerosis. Ann NY Acad Sci. 1997; 827: 310–326
   PubMed Web of Science ®Google Scholar
• Fiedler R, Mall M, Wand C, Osten B. Short term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr. 2005; 15: 253–256
   PubMed Web of Science ®Google Scholar
• Polenakovic M, Sikole A. Is erythropoietin a survival factor for red blood cells?. J Am Soc Nephrol 1996; 7: 1178–1182
   PubMed Web of Science ®Google Scholar
• Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic ß-cell turnover and function. Diabetes. 2003; 52: 726–733
   PubMed Web of Science ®Google Scholar
• Summers LKM, Fielding KA, Bradshaw VA, Ilic V, Baysen C, Clark CM, Moore MN, Frayn KN. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002; 45: 369–377
   PubMed Web of Science ®Google Scholar
• Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors. Proc Natl Acad Sci. 1997; 94: 4312–4317
   PubMed Web of Science ®Google Scholar
• Carpentier Y, Portois L, Malaisse W. n-3 fatty acids and the metabolic syndrome. Am J Clinic Nutrit. 2006; 83: S1449–S1504
   Web of Science ®Google Scholar
• Brady LM, Lovegrove SS, Lesauvage SVM, Gower BA, Minihane AM, Williams CM, Lovegrove JA. Increased n–6 polyunsaturated fatty acids do not attenuate the effects of long-chain n–3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am J Clin Nutri. 2004; 79: 983–991
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Rodrigez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in hemodialysis patients. Nephrol Dial Transplant. 2004; 19: 141–149
   PubMed Web of Science ®Google Scholar
• Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif. 2001; 19: 143–151
   PubMed Web of Science ®Google Scholar
• Berstad P, Seljeflot I, Veoierod MB, Hjerkinn EM, Arnesen H, Pedersen JI. Supplementation with fish fatty acids and oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum and non-esterified soluble vascular cell adhesion molecule-1. Clin Sci. 2003; 105: 13–20
   Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids, inflammation and immunity. Lipids. 2001; 37: 1007–1023
   Google Scholar
• Camuesco D, Gálvez J, Nieto A, Comalada M, Rodríguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J. Nutr. 2005; 135: 687–694
   PubMed Web of Science ®Google Scholar
• Fernandez-Real JM, Broch M, Vendrel J, Ricart V. Insulin resistance, inflammation, and serum fatty acids composition. Diabetes Care. 2003; 26: 1362–1368
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Manzini P, D'Antico S, Van E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004; 39: 179–187
   PubMed Web of Science ®Google Scholar